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Clinical PerspectiveWhat Is New?Our study demonstrates a specific contribution of ryanodine receptor type 2 in mediating vascular smooth muscle cell Ca^2+^‐release events relevant for regulating myogenic tone in the systemic circulation.We also found that ryanodine receptor type 2 provides a negative regulatory role in hypoxic vasoconstriction in the pulmonary circulation but does not contribute to postischemic recovery of blood flow conductance in the hind limb circulation.What Are the Clinical Implications?These findings elucidate the role and mechanism of ryanodine receptor type 2 channels in myogenic constriction and in regulating adaptive reductions in arterial diameter in response to pressure, but not flow.Our study potentially offers new possibilities for therapeutic interventions in systemic and pulmonary hypertension.

Introduction {#jah33935-sec-0008}
============

Arteries adapt to hemodynamic forces through changes in their diameter. These adaptive responses take 2 forms that reflect the operation of 2 independent mechanisms: (1) a decrease in vessel diameter in response to increased transmural *pressure*, a response termed myogenic constriction (or Bayliss effect) that is intrinsic to smooth muscle (SM) myocytes; and (2) an increase in vessel diameter in response to increased blood *flow*, reflecting the short‐ and long‐term action of shear stress on the vessel wall, the latter of which reflects outward remodeling of the vascular SM cell (VSMC) layers.[1](#jah33935-bib-0001){ref-type="ref"}

In arterial SM cells (SMCs), membrane depolarization produces a moderate (100--300 nmol/L) increase in intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~) because of influx of Ca^2+^ ions through the voltage‐dependent L‐type Ca^2+^ channel, Ca~V~1.2.[2](#jah33935-bib-0002){ref-type="ref"} This increase in global Ca^2+^ causes myocyte contraction through activation of Ca^2+^‐dependent myosin light chain kinase and induction of myosin‐actin cross‐bridge cycling.[3](#jah33935-bib-0003){ref-type="ref"} An additional important contributor to the contractility of VSMCs is the ryanodine receptor (RyR), an ion channel in the sarcoplasmic reticulum (SR) that mediates Ca^2+^ release, detected optically as "Ca^2+^ sparks." Ca^2+^ sparks are elementary Ca^2+^‐release events generated by a single Ca^2+^‐release unit composed of a cluster of RyRs in the SR.[4](#jah33935-bib-0004){ref-type="ref"}, [5](#jah33935-bib-0005){ref-type="ref"} Unlike Ca^2+^ influx via voltage‐dependent L‐type Ca^2+^ channels, Ca^2+^ release from the SR in the form of Ca^2+^ sparks paradoxically causes vasodilation.[6](#jah33935-bib-0006){ref-type="ref"}, [7](#jah33935-bib-0007){ref-type="ref"} There are 2 reasons for this counterintuitive effect of Ca^2+^ sparks. First, a single spark is capable of producing a high (10--100 μmol/L) local (≈1% of the cell volume) increase in \[Ca^2+^\]~i,~ [8](#jah33935-bib-0008){ref-type="ref"}, [9](#jah33935-bib-0009){ref-type="ref"} but increases global \[Ca^2+^\]~i~ by \<2 nmol/L.[6](#jah33935-bib-0006){ref-type="ref"}, [10](#jah33935-bib-0010){ref-type="ref"} Second, Ca^2+^ sparks occur in close proximity to the cell membrane, where every Ca^2+^ spark activates numerous large‐conductance Ca^2+^‐sensitive K^+^ (BK~Ca~) channels, causing K^+^ efflux.[8](#jah33935-bib-0008){ref-type="ref"}, [11](#jah33935-bib-0011){ref-type="ref"}, [12](#jah33935-bib-0012){ref-type="ref"}, [13](#jah33935-bib-0013){ref-type="ref"} The resultant "spontaneous transient outward currents" (STOCs) cause hyperpolarization of the cell membrane, thereby shutting off tonic Ca^2+^ entry through Ca~v~1.2 channels through channel deactivation. Therefore, the net result of Ca^2+^ spark--BK~Ca~ channel coupling is decreased global \[Ca^2+^\]~i~ and vasorelaxation.[6](#jah33935-bib-0006){ref-type="ref"}, [11](#jah33935-bib-0011){ref-type="ref"}, [12](#jah33935-bib-0012){ref-type="ref"}, [13](#jah33935-bib-0013){ref-type="ref"}, [14](#jah33935-bib-0014){ref-type="ref"}, [15](#jah33935-bib-0015){ref-type="ref"}

The ability of RyRs to produce Ca^2+^ sparks in VSMCs may depend on the RyR isoform. Mammals possess 3 subtypes of RyRs (RyR1, RyR2, and RyR3), each composed of \>5000 amino acids with a total molecular mass of ≈565 kDa.[16](#jah33935-bib-0016){ref-type="ref"}, [17](#jah33935-bib-0017){ref-type="ref"}, [18](#jah33935-bib-0018){ref-type="ref"}, [19](#jah33935-bib-0019){ref-type="ref"} The 3 RyRs show 66% to 70% overall amino acid identity,[20](#jah33935-bib-0020){ref-type="ref"} and all 3 RyR isoforms are expressed in arterial SM.[21](#jah33935-bib-0021){ref-type="ref"}, [22](#jah33935-bib-0022){ref-type="ref"} Coussin et al[23](#jah33935-bib-0023){ref-type="ref"} suggested that both RyR1 and RyR2 contribute to spontaneous Ca^2+^ sparks in cultured VSMCs from the portal vein, a suggestion supported by the observation that antisense oligonucleotides against RyR3 had no effect on spontaneous Ca^2+^ spark activity.[24](#jah33935-bib-0024){ref-type="ref"} Consistent with this, we previously showed that the peak amplitude, width, and duration of Ca^2+^ sparks in freshly isolated cerebral VSMCs from RyR3‐deficient (*Ryr3* ^−/−^) mice were normal.[25](#jah33935-bib-0025){ref-type="ref"} However, the frequency of Ca^2+^ sparks was higher in RyR3‐deficient VSMCs than in wild‐type cells, suggesting that RyR3 might play a role in modulating RyR1 and/or RyR2 function. A specific role of RyR1 in SR Ca^2+^ release in pulmonary artery VSMCs was suggested on the basis of the observation that hypoxia‐induced increases in \[Ca^2+^\]~i~ and contraction were largely eliminated in *Ryr1* ^+/‐^ VSMCs.[26](#jah33935-bib-0026){ref-type="ref"} However, results from global gene knockout mouse models are difficult to interpret because of possible confounding effects of compensatory mechanisms. In addition, the contributions of the RyR2 subtype to arterial elementary Ca^2+^ signaling and adaptive responses in the vasculature remain unclear.

Herein, we established the first tamoxifen‐inducible, SM‐specific RyR2‐knockout (SM‐*Ryr2* ^*−/−*^) mouse model to test the hypothesis that RyR2 contributes to SR Ca^2+^ release in arterial VSMCs. Unexpectedly, we found that the RyR2 isoform plays a dominant role in local and global VSMC SR Ca^2+^ release in both systemic and pulmonary arteries. We further found that the expression of VSMC RyR2 is an essential prerequisite for the formation of Ca^2+^ sparks, which limit arterial myogenic constriction to *pressure*. Furthermore, we found that RyR2 plays an important role in the pulmonary artery pressure response to sustained hypoxia but does not contribute to *flow*‐induced increases in pulmonary arterial pressure. Finally, RyR2 does not contribute to postischemic recovery of *blood flow* in a hind limb occlusion model.

Methods {#jah33935-sec-0009}
=======

The data that support the findings of this study are available from the corresponding author on reasonable request.

Mouse Model {#jah33935-sec-0010}
-----------

Animal care followed American Physiological Society guidelines. All animal protocols were approved by the local animal care committee (LAGeSo, Berlin, Germany) and the animal welfare officers of the Max Delbrück Center for Molecular Medicine. There are no ethical concerns. Mice were maintained in individually ventilated cages (IVC, Techniplast, Germany) under standardized conditions with a 12‐hour dark‐light cycle and free access to standard chow (0.25% sodium; SSNIFF Spezialitäten, Soest, Germany) and drinking water. SM‐*Ryr2* ^*−/−*^ conditional knockout mice were created by crossbreeding mice containing an *Ryr2* gene containing a *lox*P‐flanked region (Figure [1](#jah33935-fig-0001){ref-type="fig"}A) (crr^m1^)[27](#jah33935-bib-0027){ref-type="ref"} with mice containing tamoxifen‐dependent Cre recombinase[28](#jah33935-bib-0028){ref-type="ref"} under the control of the endogenous SM22α gene locus, which is selectively expressed in SM of adult mice.[29](#jah33935-bib-0029){ref-type="ref"} The SMAKO mouse,[2](#jah33935-bib-0002){ref-type="ref"}, [30](#jah33935-bib-0030){ref-type="ref"} carrying *lox*P‐flanked Ca~V~1.2 channel genes and the SM--tamoxifen‐dependent Cre recombinase knock‐in transgene (SM22α‐Cre^T2^),[29](#jah33935-bib-0029){ref-type="ref"} served as a source of the SM22α‐Cre^T2^ in breeding experiments. The floxed variant of the Ca~v~1.2 channel gene was eliminated after 2 generations of breeding, resulting in the *Ryr2* ^flox/flox^;SM22α‐Cre^T2^ mice used for experiments. SM‐*Ryr2* ^*−/−*^ (*Ryr2* ^flox/flox^;SM22α‐Cre^T2^ or *Ryr2* ^flox/flox^;SM22α‐Cre^T2/T2^) male mice (20--30 g, 8--14 weeks old) and littermate or age‐matched controls (*Ryr2* ^+/+^;SM22α‐Cre^T2/T2^, *Ryr2* ^+/+^;SM22α‐Cre^T2^, *Ryr2* ^+/+^, *Ryr2* ^flox/+^, or *Ryr2* ^flox/flox^) were injected IP with tamoxifen (30 μg/mg body weight) on 6 consecutive days. Mice showed no gross anomalies before or after inducing *Ryr2* gene deletion in SM by tamoxifen treatment. Isolated arteries were usually obtained after ≈2 to 3 days after tamoxifen treatment. The SM myosin heavy chain--Cre[31](#jah33935-bib-0031){ref-type="ref"} line was from Stefan Offermanns (Max‐Planck‐Institut für Herz‐und Lungenforschung, Bad Nauheim, Germany).

![Conditional knockout of ryanodine receptor type 2 (RyR2) in vascular smooth muscle (SM) cells. **A**, Schematic representation of the RyR2 wild‐type (WT) allele, the allele containing loxP sequences (L2), and the floxed allele after the action of Cre recombinase (L1). **B**, Western blot analysis of RyR2 protein in aortic and heart tissues from control and SM‐*Ryr2* ^*−/−*^ mice; 40 μg aortic tissue and 10 μg heart tissue were loaded per lane. **C**, Immunohistochemical detection of WT (control) and SM‐*Ryr2* ^*−/−*^ aortae. Red indicates RyR2 staining; blue indicates stained nuclei (4',6‐diamidino‐2‐phenylindole \[DAPI\]); green represents nonspecific autofluorescence. **D**, RyR1, RyR2, and RyR3 mRNA expression in aortic tissue. RyR1/2/3 mRNA levels were normalized against 18s mRNA. Mean mRNA expression value was arbitrarily set at 1 for WT control tissue, and relative expression was calculated for SM‐*Ryr2* ^*−/−*^ tissue (n=3 mice, RyR1 and RyR3 samples; n=6 mice, RyR2 WT; n=7 mice, RyR2 knockout). A.U. indicates arbitrary unit; SM‐CreER^T2^, SM--tamoxifen‐dependent Cre recombinase. \**P*\<0.01 vs WT (unpaired *t* test).](JAH3-8-e010090-g001){#jah33935-fig-0001}

Western Blot Analysis {#jah33935-sec-0011}
---------------------

Thoracic aortae and hearts were isolated from mice and placed into cold physiological saline solution (PSS) previously oxygenated for 30 minutes (95% O~2~, 5% CO~2~). The composition of PSS (in mmol/L) was as follows: 119 NaCl, 4.7 KCl, 1.2 KH~2~PO~4~, 25 NaHCO~3~, 1.2 Mg~2~SO~4~, 11.1 glucose, and 1.6 CaCl~2~. Vessels were cleaned of perivascular fat, and all tissues were immediately placed on dry ice and kept at −80°C until use. Samples were homogenized in radioimmunoprecipitation assay buffer (Cell Signaling Technology, Danvers, MA) containing protease inhibitors (Sigma‐Aldrich, Taufkirchen, Germany). Tubes containing homogenates were freeze thawed 3 times at −80°C and 37°C, respectively, and then centrifuged at 9000*g* for 20 minutes at 4°C. After determining the protein concentration, samples prepared in Laemmli buffer (50 mmol/L Tris, pH 6.8, 10% SDS, 10% glycerol, 5% mercaptoethanol, and 2 mg/mL bromophenol blue) were boiled for 2 minutes, separated by SDS‐PAGE on 7% polyacrylamide gels, and transferred onto polyvinylidene fluoride membranes. Membranes were blocked in 5% nonfat dry milk in PBS containing 0.1% Tween 20, and then incubated overnight at 4°C with primary anti‐RyR2 antibody (catalog No. MA3916, 1:800 final dilution; Pierce Biotechnology). After washing, membranes were incubated with anti‐mouse IgG‐peroxidase--linked secondary antibody (1:5000 final dilution; GE Healthcare, UK) for 1 hour at room temperature. Blots were washed and incubated in enhanced chemiluminescence reagents (ECL Prime; Amersham Bioscience, UK), after which bands were detected using a ChemiDoc XRS+ Imaging System (Bio‐Rad, Hercules, CA). An anti‐GAPDH antibody (catalog No. AM4300, 1:4000 final dilution; Ambion) was used as a loading control, and Precision Plus Protein Prestained Standard (Bio‐Rad, Germany) was used as a molecular weight marker.

Immunohistochemistry {#jah33935-sec-0012}
--------------------

Isolated aortae were fixed in 4% formaldehyde solution for 1 hour on ice, after which they were incubated first in 3 mL of 50 mmol/L NH~4~Cl for 30 minutes on ice and then in 3 mL of 30% sucrose solution containing 2 mmol/L MgCl~2~ overnight at 4°C. Fixed aortae were placed in Tissue‐Tek and stored at −80°C. For immunohistochemistry, 5‐μm cryosections of aortae were incubated with rabbit polyclonal anti‐RyR2 primary antibody (AB9080; Merck Millipore, Germany), diluted 1:500. Sections were incubated in 10% normal donkey serum (Jackson ImmunoResearch Laboratories, Inc) for 30 minutes to block nonspecific binding sites, and then incubated with primary antibody for 1 hour at room temperature. All incubations were performed in a humidified chamber. For fluorescence visualization of bound primary antibody, sections were further incubated with anti‐rabbit Cy3‐conjugated secondary antibody (Jackson ImmunoResearch Laboratories, Inc) for 1 hour in a humidified chamber at room temperature. Specimens were examined under a Zeiss Axioplan‐2 imaging microscope and analyzed with AxioVision 4.8 software (Zeiss) by an investigator blinded to group‐assignment information.

RNA Isolation and Quantitative Reverse Transcription--Polymerase Chain Reaction {#jah33935-sec-0013}
-------------------------------------------------------------------------------

Total RNA was isolated from snap‐frozen fat‐free aortae using the RNeasy RNA isolation kit (Qiagen). RNA concentration and quality were measured using a NanoDrop‐1000 spectrophotometer (PeqLab Biotechnologie, Germany). cDNA was synthesized by reverse transcription from 2 μg of total RNA (Applied Biosystems). Target mRNA expression levels were analyzed by quantitative reverse transcription--polymerase chain reaction using SYBR green reagents and an Applied Biosystems 7500 Sequence Detector (Applied Biosystems). Expression levels of the target *Ryr2* gene, determined using the relative standard curve method, were normalized to those of 18s RNA. The following primer pairs were used: *Ryr*1, 5′‐ATGACCGTAGGGCTCCTGGCCGTAG‐3′ (forward) and 5′‐GGGTCCTCGATCTCGTCCCCGA‐3′ (reverse); *Ryr*2, 5′‐CTACCCGAACCTCCAGCGATACT‐3′ (forward) and 5′‐GCAAAAGAAGGAGATGATGGTGTG‐3′ (reverse); *Ryr*3, 5′‐ATTCTGACCAGCTCTTCCGC‐3′ (forward) and 5′‐TCTTCCGTTCCTGGTCCTGT‐3′ (reverse); and 18s RNA, 5′‐ACATCCAAGGAAGGCAGCAG‐3′ (forward) and 5′‐TTTTCGTCACTACCTCCCCG‐3′ (reverse).

Wire Myography {#jah33935-sec-0014}
--------------

The thoracic aorta and mesenteric, tibial, femoral, and cerebral arteries were removed immediately after euthanizing the mouse, quickly transferred to cold (4°C), oxygenated (95% O~2~/5% CO~2~) PSS (consisting of the following \[in mmol/L\]: 119 NaCl, 4.7 KCl, 1.2 KH~2~PO~4~, 25 NaHCO~3~, 1.2 Mg~2~SO~4~, 11.1 glucose, and 1.6 CaCl~2~), dissected into 2‐mm rings, and trimmed of perivascular fat and connective tissue. The composition of 60 mmol/L KCl PSS (in mmol/L) was as follows: 63.7 NaCl, 60 KCl, 1.2 KH~2~PO~4~, 25 NaHCO~3~, 1.2 Mg~2~SO~4~, 11.1 glucose, and 1.6 CaCl~2~. Each ring was positioned between 2 stainless steel wires (diameter, 0.0394 or 0.025 mm) in a 5‐mL organ bath of a Mulvany Small Vessel Myograph (DMT 610 M; Danish Myo Technology, Denmark) filled with PSS. The bath solution was continuously oxygenated with a 95% O~2~/5% CO~2~ gas mixture and kept at 37°C (pH 7.4). Aortic rings were placed under a tension of 0.3 g,[32](#jah33935-bib-0032){ref-type="ref"} whereas mesenteric, tibial, femoral, and cerebral rings were placed under a tension equivalent to that generated at 0.9 times the diameter of the vessel at 100 mm Hg. This normalization procedure was performed to obtain the passive diameter of the vessel at 100 mm Hg.[32](#jah33935-bib-0032){ref-type="ref"} Chart5 software (AD Instruments Ltd, Spechbach, Germany) was used for data acquisition and display. Rings were precontracted with 60 mmol/L KCl PSS and equilibrated until a stable resting tension was attained. In some experiments, vessels were treated sequentially with repeated doses of 10 mmol/L caffeine at increasing time intervals (1, 2, 3, 4, and 5 minutes). Drugs were added to the bath solution unless indicated otherwise. Tension is expressed as a percentage of the steady‐state tension (100%) obtained with isotonic external 60 mmol/L KCl.

Video Microscopic Ca^2+^ and Diameter Imaging {#jah33935-sec-0015}
---------------------------------------------

Ca^2+^ events in mesenteric arteries (third‐ and fourth‐order branches) were studied after loading with the Ca^2+^‐binding fluorescent dye Fluo‐4‐AM (10 μmol/L) in the presence of pluronic acid (2.5 μg/mL) in a solution consisting of the following (in mmol/L): 134 NaCl, 6 KCl, 10 glucose, 1 MgCl~2~, 2 CaCl~2~, and 10 HEPES (pH 7.4). After loading, the tissue was placed in a chamber specialized for Ca^2+^ imaging and superfused with PSS at a rate of 1 to 2 mL/min at 37°C. Images were collected with a Noran Oz laser‐scanning confocal microscope and Nikon ×60 water‐immersion (numerical aperture, 1.2) fluorescence objectives with the aid of software developed by Prairie Technologies (Middleton, WI). Fluo‐4 was excited with a krypton‐argon laser at 488 nm, and the emitted fluorescence was collected at \>500 nm. Each file was recorded for 30 to 60 seconds, and images were collected at a rate of 53 images/s. Imaging fields were 131×131 μm (256×256 pixels).[33](#jah33935-bib-0033){ref-type="ref"} The diameter of pressurized arteries was monitored, as previously described.[34](#jah33935-bib-0034){ref-type="ref"}

Isolation of Arterial VSMCs {#jah33935-sec-0016}
---------------------------

VSMCs from tibial and mesenteric arteries were isolated, as described.[12](#jah33935-bib-0012){ref-type="ref"}, [14](#jah33935-bib-0014){ref-type="ref"} Briefly, arteries were removed and quickly transferred to cold (4°C), oxygenated (95% O~2~--5% CO~2~) PSS. The arteries were then cleaned, cut into pieces, and incubated for 50 minutes at 37°C in Ca^2+^‐free Hank\'s solution consisting of the following (in mmol/L): 55 NaCl, 80 sodium glutamate, 5.6 KCl, 2 MgCl~2~, 10 glucose, and 10 HEPES (pH 7.4 with NaOH) containing 1 mg/mL BSA (Sigma, Taufkirchen, Germany), 0.5 mg/mL papain (Sigma), and 1.0 mg/mL dithiothreitol. The segments were then placed in Hank\'s solution containing 1 mg/mL collagenase (types F and H; ratio, 30% and 70%, respectively; Sigma) and 0.1 mmol/L CaCl~2~ for 10 minutes at 37°C. After several washes in Ca^2+^‐free Hank\'s solution (containing 1 mg/mL BSA), single cells were dispersed from artery segments by gently triturating. Cells were then stored in the same solution at 4°C.

Ca^2+^ Sparks {#jah33935-sec-0017}
-------------

VSMCs were seeded onto glass coverslips and incubated with the Ca^2+^ indicators Fluo‐3‐AM or Fluo‐4‐AM (10 μmol/L) and pluronic acid (0.005%, w/v) for 60 minutes on ice (in the same bath solution used for patch‐clamp measurements).[30](#jah33935-bib-0030){ref-type="ref"} After loading, the cells were washed with bath solution for at least 10 minutes at room temperature. Single SMCs were imaged (at 20--59 frames/s) using a Nipkow disc‐based UltraView LCI confocal scanner (Perkin Elmer, Waltham, MA) linked to a fast digital camera. The confocal system was mounted on an inverted Diaphot microscope with a ×40 oil‐immersion objective (numerical aperture, 1.3; Nikon). Images were obtained by illumination with an argon laser at 488 nm and by recording all emitted light \>515 nm. Ca^2+^ spark analyses were performed off‐line using the UltraView Imaging Suite software (Perkin Elmer). Ca^2+^ sparks were defined as local fractional fluorescence increases that were clearly above the noise level. Ca^2+^ spark frequency was calculated as the number of detected sparks divided by the total scan time. Line‐scan images were obtained with a Bio‐Rad imaging system (Munich, Germany) attached to a Nikon Diaphot microscope[25](#jah33935-bib-0025){ref-type="ref"}, [35](#jah33935-bib-0035){ref-type="ref"} by illumination with a krypton‐argon laser at 488 nm and by recording all emitted light \>500 nm.

Electrophysiology {#jah33935-sec-0018}
-----------------

K^+^ currents were measured in the conventional whole‐cell configuration of the patch‐clamp technique at room temperature, as previously described.[30](#jah33935-bib-0030){ref-type="ref"}, [36](#jah33935-bib-0036){ref-type="ref"} Patch pipettes (resistance, 3--5 MΩ) were filled with a solution containing the following (in mmol/L): 110 K‐Aspartate, 30 KCl, 10 NaCl, 1 MgCl~2~, and 0.05 EGTA (pH 7.2). For measurement of K^+^ currents in the whole‐cell perforated‐patch mode, the patch pipette solution was supplemented with 200 μg/mL amphotericin B, dissolved in dimethyl sulfoxide. The external bath solution contained the following (in mmol/L): 134 NaCl, 6 KCl, 1 MgCl~2~, 2 CaCl~2~, 10 glucose, and 10 HEPES (pH 7.4). The holding potential was −60 mV. Whole‐cell currents were recorded using an Axopatch 200B (Axon Instruments/Molecular Devices, Sunnyvale, CA) or EPC 7 (List, Darmstadt, Germany) amplifier and digitized at 5 kHz using a Digidata 1440A digitizer (Axon CNS, Molecular Devices) and pClamp software versions 10.1 and 10.2. STOC analysis was performed off‐line using IGOR Pro (WaveMetrics, Lake Oswego, OR) and Excel (Microsoft Corporation, Redmond, WA).

Telemetry {#jah33935-sec-0019}
---------

Radiotelemetric blood pressure measurements were performed on adult C57Bl6 SM‐*Ryr2* ^*−/−*^ mice, as described elsewhere.[37](#jah33935-bib-0037){ref-type="ref"} After implanting blood pressure devices, mice were allowed ≈2 weeks to recover from surgery and exhibit regular diurnal activity rhythms. Targeted deletion of *Ryr2* was induced by administration of tamoxifen (see above).

Femoral Artery Occlusion Model and Assessment of Blood Flow by Laser Doppler Imaging {#jah33935-sec-0020}
------------------------------------------------------------------------------------

Occlusion of the right femoral artery in 12‐week‐old mice was performed, as described previously.[38](#jah33935-bib-0038){ref-type="ref"} For repetitive assessment of hind limb blood flow after occlusion, we used the noninvasive laser Doppler imaging technique.[38](#jah33935-bib-0038){ref-type="ref"} The laser Doppler imaging technique depends on the Doppler principle, whereby low‐power light from a monochromatic stable laser (wavelength, 830 nm; laser diode; model LDI2‐HR; Moor Instruments, UK), incident on tissue, is scattered by moving red blood cells, photodetected, and processed to provide a measurement of blood flow. Artery structure of right and left hind limbs was characterized after polyurethane treatment.[39](#jah33935-bib-0039){ref-type="ref"}

Hypoxic and Caffeine‐Induced Pulmonary Vasoconstriction in Isolated Perfused and Ventilated Mouse Lungs {#jah33935-sec-0021}
-------------------------------------------------------------------------------------------------------

Lungs were prepared, as described previously.[40](#jah33935-bib-0040){ref-type="ref"} Briefly, lungs were perfused with 37°C sterile Krebs‐Henseleit hydroxyethyl amylopectin buffer (1 mL/min; Serag‐Wiesner, Naila, Germany) containing indomethacin (30 μmol/L; Sigma) and Nω‐nitro‐[l]{.smallcaps}‐arginine methyl ester hydrochloride (1 mmol/L; Sigma) in a nonrecirculating manner; left atrial pressure was adjusted to 2.2 cm H~2~O. After isolation, lungs were ventilated with negative pressure in a closed chamber, volume controlled with a tidal volume of ≈8 mL/kg body weight, an end‐expiratory pressure of −2 cm H~2~O, and a respiratory rate of 90 breaths/min. Hyperinflation (−24 cm H~2~O) was performed at 4‐minute intervals. Mean pulmonary arterial pressure was continuously monitored, and the difference in mean pulmonary arterial pressure was expressed in cm H~2~O. After an initial steady‐state period of 10 minutes, lungs were perfused at a flow rate of 0.5, 1, 1.5, and 2 mL/min for 30 seconds each to generate a 4‐point pressure‐flow curve under normoxic conditions. Flow was then set to 1 mL/min and, after another steady‐state period of 4 minutes, mean pulmonary arterial pressure was recorded in response to a change from normoxic to hypoxic (1% O~2~) ventilation.[41](#jah33935-bib-0041){ref-type="ref"} Second and third pressure‐flow curves were generated during hypoxic pulmonary vasoconstriction phase 1 and phase 2, respectively. After 88 minutes of hypoxia, normoxic ventilation was reestablished and, after another steady‐state period of 22 minutes, caffeine (10 mmol/L) was administered to the perfusate for 2 minutes; this latter step was repeated twice at 12‐minute intervals.

Materials {#jah33935-sec-0022}
---------

Fluo‐3‐AM and Fluo‐4‐AM were purchased from Molecular Probes (Eugene, OR), and A23187 was from AppliChem (Darmstadt, Germany). The antibody against RyR2 was from Millipore/Chemicon (Schwalbach/Ts, Germany). All salts and other drugs were obtained from Sigma‐Aldrich (Munich, Deisenhofen, or Schnelldorf, Germany) or Merck (Darmstadt, Germany). In cases in which dimethyl sulfoxide was used as a solvent, the maximal dimethyl sulfoxide concentration after application did not exceed 0.5%.

Statistical Analysis {#jah33935-sec-0023}
--------------------

Data are presented as means±SEM. Descriptive statistics were calculated, and variables were examined for meeting assumptions of normal distribution without skewness and kurtosis by using quantile‐quantile plot, Shapiro‐Wilk test, or D\'Agostino and Pearson omnibus normality test, as appropriate.[42](#jah33935-bib-0042){ref-type="ref"} Statistically significant differences in mean values were determined by Student unpaired *t* test or one‐way ANOVA. The Mann‐Whitney *U* test was performed for comparison of dose‐response curves. Statistical tests were performed using GraphPad Prism (San Diego, CA), R (R Foundation for Statistical Computing, Vienna, Austria), or Excel (Microsoft Corporation). In the quantitative polymerase chain reaction experiments, mean mRNA expression value was arbitrarily set at 100% for wild‐type control tissue, and relative expression was calculated for SM‐*Ryr2* ^*−/−*^ tissue, as previously described for small amounts of tissues.[43](#jah33935-bib-0043){ref-type="ref"} *P*\<0.05 was considered statistically significant.

Results {#jah33935-sec-0024}
=======

SM‐*Ryr2* ^*−/−*^ mice, generated by SMC‐targeted deletion of the *Ryr2* gene by tamoxifen‐dependent Cre recombinase under the control of the endogenous SM22α gene locus (Figure [1](#jah33935-fig-0001){ref-type="fig"}A), showed virtually no detectable RyR2 mRNA in aortic, mesenteric, and tibial artery tissues compared with control mice and completely lacked RyR2 protein (Figure [1](#jah33935-fig-0001){ref-type="fig"}B through [1](#jah33935-fig-0001){ref-type="fig"}D, Figure [S1](#jah33935-sup-0001){ref-type="supplementary-material"}B and [S1](#jah33935-sup-0001){ref-type="supplementary-material"}C).

RyR2s in Global SR Ca^2+^ Release in Peripheral Arteries {#jah33935-sec-0025}
--------------------------------------------------------

We next studied the contribution of RyR2 to global SR Ca^2+^ release and arterial contraction. SR Ca^2+^ release was induced by the pan RyR activator caffeine (10 mmol/L). As shown in Figure [2](#jah33935-fig-0002){ref-type="fig"}A and [2](#jah33935-fig-0002){ref-type="fig"}B, caffeine induced strong contractions of the aorta and mesenteric, femoral, tibial, and cerebral arteries of control mice. In contrast, caffeine (10 mmol/L) was largely ineffective in inducing contraction in any of these arteries from SM‐*Ryr2* ^*−/−*^ mice (Figure [2](#jah33935-fig-0002){ref-type="fig"}A and [2](#jah33935-fig-0002){ref-type="fig"}B). These data indicate that the RyR2 isoform is the predominant contributor to SR Ca^2+^‐release--induced contraction of peripheral arteries.

![Effects of caffeine on peripheral artery contraction. **A**, Original recordings of contractile force of mesenteric arteries from wild‐type (control) and smooth muscle (SM)--*Ryr2* ^*−/−*^ mice. Addition of caffeine (10 mmol/L) into the bath solution is indicated by arrows. **B**, Effects of caffeine on contractile force in various arteries from wild‐type mice (n=13 mesenteric arteries of 2 mice; n=4 femoral arteries of 2 mice; n=22 tibial arteries of 3 mice; n=12 aortae of 2 mice; n=10 cerebral arteries of 5 mice) and SM‐*Ryr2* ^*−/−*^ mice (n=16 mesenteric arteries of 2 mice; n=6 femoral arteries of 3 mice; n=24 tibial arteries of 4 mice; n=6 aortae and n=8 cerebral arteries of 5 mice). **C**, Contraction of mesenteric arteries with repeated applications of caffeine (10 mmol/L) at different time intervals (n=13 control rings; n=16 rings). **D**, Concentration‐response curves for the contractile effects of phenylephrine in mesenteric arteries of control and SM‐*Ryr2* ^*−/−*^ mice (n=24 rings). **E**, Contraction of mesenteric arteries in response to repeated applications of phenylephrine (1 μmol/L) in a Ca^2+^‐free bath solution (n=24 rings of 3 mice each in **C** through **E**). There were no differences between control and SM‐*Ryr2* ^*−/−*^ rings. n.s. indicates not significant. \**P*\<0.05.](JAH3-8-e010090-g002){#jah33935-fig-0002}

The role of RyR2 in VSMC Ca^2+^ release after refilling of SR Ca^2+^ stores was next investigated using a protocol of repeated caffeine applications at varying time intervals. Mesenteric arteries from control mice showed normal contractions in response to caffeine (10 mmol/L) after an interval of 5 minutes between caffeine applications (Figure [2](#jah33935-fig-0002){ref-type="fig"}C), indicating that VSMC RyR‐sensitive SR Ca^2+^ stores are refilled within 5 minutes after SR Ca^2+^ depletion by this RyR activator. In contrast, vessels originating from SM‐*Ryr2* ^*−/−*^ mice showed weak contractions in response to caffeine at all time intervals (Figure [2](#jah33935-fig-0002){ref-type="fig"}A and [2](#jah33935-fig-0002){ref-type="fig"}C). These results support the interpretation that RyR2 is the major isoform in VSMCs involved in RyR‐dependent SR Ca^2+^ release. In keeping with this, caffeine (10 mmol/L) induced a prominent increase in arterial wall \[Ca^2+^\]~i~ in control mesenteric arteries (Figure [3](#jah33935-fig-0003){ref-type="fig"}, upper), but not in SM‐*Ryr2* ^*−/−*^ mesenteric arteries (Figure [3](#jah33935-fig-0003){ref-type="fig"}, lower), as measured by video microscopy using Fluo‐4‐AM--loaded vessels. However, vascular contractions in response to the α~1~‐adrenergic receptor agonist phenylephrine were normal in SM‐*Ryr2* ^*−/−*^ arteries in both Ca^2+^‐containing PSS (Figure [2](#jah33935-fig-0002){ref-type="fig"}D) and Ca^2+^‐free PSS (Figure [2](#jah33935-fig-0002){ref-type="fig"}E). These latter results indicate that RyR2 deficiency does not affect phenylephrine‐induced contractions of VSMCs in mesenteric arteries.

![Changes in arterial wall intracellular Ca^2+^ concentration. Ca^2+^ fluorescence video microscopy images of mesenteric arteries from wild‐type (WT; **upper**) and smooth muscle (SM)--*Ryr2* ^*−/−*^ (**lower**) mice before (**left**) and after (**right**) application of caffeine.](JAH3-8-e010090-g003){#jah33935-fig-0003}

RyR2s in Local Ca^2+^ Release in VSMCs of Peripheral Arteries {#jah33935-sec-0026}
-------------------------------------------------------------

Ca^2+^ sparks are local, elementary Ca^2+^‐release events mediated by RyRs that activate nearby BK~Ca~ channels to oppose arterial constriction to elevations in transmural pressure. Using our SM‐*Ryr2* ^*−/−*^ mice in conjunction with Nipkow spinning‐disc confocal microscopy, we investigated the role of RyR2 in the generation and properties of Ca^2+^ sparks.

Ca^2+^ sparks were readily detected in tibial artery SMCs from wild‐type mice, as shown in Figure [4](#jah33935-fig-0004){ref-type="fig"}A through [4](#jah33935-fig-0004){ref-type="fig"}C, which depicts fluorescence images of a representative Fluo‐4--loaded cell. Two regions of interest (ROIs), denoted by yellow circles *a* and *b* (Figure [4](#jah33935-fig-0004){ref-type="fig"}A), are highlighted; these correspond to nonspark and spark sites, respectively, as shown in Figure [4](#jah33935-fig-0004){ref-type="fig"}B. Continuous recordings of changes in fluorescence intensity over time revealed recurring Ca^2+^ sparks in ROI *b* (Figure [4](#jah33935-fig-0004){ref-type="fig"}C, highlighted in detail in the inset), but not in ROI *a*. Figure [4](#jah33935-fig-0004){ref-type="fig"}C also shows that subsequent application of 10 mmol/L caffeine, which causes activation of RyRs and release of SR Ca^2+^, induced a transient increase in global \[Ca^2+^\], detectable in both ROIs. Shortly after the caffeine‐induced increase in global \[Ca^2+^\], Ca^2+^ sparks were no longer detectable in ROI *b*, consistent with the fact that depletion of SR Ca^2+^ by caffeine eliminates the Ca^2+^ gradient that drives RyR‐mediated SR Ca^2+^ release, causing Ca^2+^ sparks to disappear. Notably, VSMCs from SM‐*Ryr*2^*−/−*^ mice showed little or no global \[Ca^2+^\]~i~ transient in response to treatment with 10 mmol/L caffeine (Figure [4](#jah33935-fig-0004){ref-type="fig"}D and [4](#jah33935-fig-0004){ref-type="fig"}G). Moreover, although the majority (87%) of VSMCs from control mice exhibited Ca^2+^ sparks (n=15), with an average frequency of 0.59±0.10 Hz, Ca^2+^ sparks were undetectable in VSMCs from SM‐*Ryr2* ^*−/−*^ mice (n=11) (Figure [4](#jah33935-fig-0004){ref-type="fig"}E and [4](#jah33935-fig-0004){ref-type="fig"}F). We confirmed our results using another transgenic mouse line in which Cre recombinase expression is driven by the SM myosin heavy chain promoter.[44](#jah33935-bib-0044){ref-type="ref"} Reverse transcription--polymerase chain reaction showed that RyR2 mRNA was almost undetectable in aortic tissue, as well as mesenteric and tibial arteries, of SM myosin heavy chain--*Ryr2* ^*−/−*^ mice compared with control mice (Figure [5](#jah33935-fig-0005){ref-type="fig"}A); and tibial artery SMCs from these mice lacked Ca^2+^ sparks (Figure [5](#jah33935-fig-0005){ref-type="fig"}B through [5](#jah33935-fig-0005){ref-type="fig"}H). By contrast, Ca^2+^ sparks were present in 55.3% of VSMCs from control mice (n=123), albeit at a reduced frequency (0.06±0.01 Hz) compared with VSMCs from wild‐type littermates of SM‐*Ryr2* ^*−/−*^ mice (Figure [5](#jah33935-fig-0005){ref-type="fig"}F and [5](#jah33935-fig-0005){ref-type="fig"}G). Additional experiments performed in SMCs from mesenteric arteries showed that 28% of wild‐type (control) cells exhibited Ca^2+^ sparks (n=127), whereas no Ca^2+^ sparks were observed in VSMCs from SM‐*Ryr2* ^*−/−*^ mice (n=104) (Figure [S2](#jah33935-sup-0001){ref-type="supplementary-material"}). Control VSMCs also showed a strong increase in \[Ca^2+^\]~i~ in response to 10 mmol/L caffeine, but VSMCs from SM‐*Ryr2* ^*−/−*^ mice were largely unresponsive (Figure [S2](#jah33935-sup-0001){ref-type="supplementary-material"}).

![Ca2+‐release events (Ca^2+^ sparks) in wild‐type and smooth muscle (SM)--*Ryr2* ^*−/−*^ vascular SM cells (VSMCs). **A**, Ca^2+^ fluorescence image of a Fluo‐4--loaded wild‐type (control) tibial artery SMC. **B**, Ca^2+^ fluorescence image of the same cell as in **A** during the occurrence of a Ca^2+^ spark. Two‐dimensional images were recorded at a rate of 20/s. **C**, Time course of Ca^2+^ fluorescence changes in cellular regions of interest (ROIs) without sparks (ROI *a*,**upper**) and with sparks (ROI *b*,**lower**). Presence of 10 mmol/L caffeine is indicated by horizontal lines. **D**, Time course of Ca^2+^ fluorescence changes in a ROI (similar size as in **A**) of an SM‐*Ryr2* ^*−/−*^ VSMC in the absence and presence of caffeine (10 mmol/L). **E**, Percentage of VSMCs with Ca^2+^ sparks. **F**, Ca^2+^ spark frequencies in n=15 wild‐type and n=11 SM‐*Ryr2* ^*−/−*^ VSMCs. **G**, Increases in peak Ca^2+^ fluorescence induced by 10 mmol/L caffeine in wild‐type (control) and SM‐*Ryr2* ^*−/−*^ VSMCs (n=14 cells and n=8 cells, respectively; 3 mice). F/F0, flurescence/background fluorescence. \**P*\<0.05.](JAH3-8-e010090-g004){#jah33935-fig-0004}

![Ca2+‐release events (Ca^2+^ sparks) in wild‐type and smooth muscle myosin heavy chain (SMMHC)--*Ryr2* ^*−/−*^ tibial artery smooth muscle cells (SMCs). **A**, Ryanodine receptor type 2 (RyR2) mRNA expression in aortic, mesenteric artery, and tibial artery tissues. mRNA levels for RyR2 were normalized against 18s mRNA. The mean mRNA expression value was arbitrarily set at 100 for wild‐type (control) tissue, and relative expression was calculated for SMMHC‐*RyR2* ^*−/−*^ tissue (n=4 each). *P* value is given vs control (1‐sample *t* test). **B**, Ca^2+^ fluorescence image of a Fluo‐4‐AM--loaded control vascular SMC (VSMC). **C**, Ca^2+^ fluorescence image of the same cell as in **A** during the occurrence of a Ca^2+^ spark. Two‐dimensional images were recorded at a rate of 5/s. **D**, Time course of Ca^2+^ fluorescence changes in cellular regions of interest (ROIs) without sparks (ROI *a*,**left**) and with sparks (ROI *b*,**right**). **E**, Time course of Ca^2+^ fluorescence changes in an ROI (similar size as that in **A**) of an SMMHC‐*Ryr2* ^*−/−*^ VSMC. **F**, Percentage of VSMCs with Ca^2+^ sparks. **G**, Ca^2+^ spark frequencies in VSMCs from control and SMMHC‐*Ryr2* ^*−/−*^ mice. **H**, Amplitude of Ca^2+^ sparks (n=123 cells of 4 control mice; n=124 cells of 4 SMMHC‐*Ryr2* ^*−/−*^ mice). A.U. indicates arbitrary unit. F/F0, flurescence/background fluorescence. \**P*\<0.05.](JAH3-8-e010090-g005){#jah33935-fig-0005}

Although our results indicate an essential role for RyR2 in mediating Ca^2+^ release in the form of sparks in VSMCs, other reports have suggested that SMCs also express RyR1 and RyR3.[21](#jah33935-bib-0021){ref-type="ref"}, [22](#jah33935-bib-0022){ref-type="ref"}, [45](#jah33935-bib-0045){ref-type="ref"} Therefore, we used high‐resolution, confocal line‐scan imaging of VSMCs to further confirm the role of RyR2 in Ca^2+^ spark formation, measuring Ca^2+^ sparks in close proximity to the cell surface.[30](#jah33935-bib-0030){ref-type="ref"} Figure [6](#jah33935-fig-0006){ref-type="fig"}A shows a confocal line‐scan image of 2 Ca^2+^ sparks in a representative tibial artery SMC isolated from a control mouse. Ca^2+^ sparks occurred at a frequency of 0.46±0.10 Hz (n=52) in tibial SMCs from these mice (Figure [6](#jah33935-fig-0006){ref-type="fig"}B), but were essentially absent (frequency, 0.02±0.01 Hz; n=42) in VSMCs from SM‐*Ryr2* ^*−/−*^ mice. Together, these data demonstrate that RyR2s are indispensable for Ca^2+^ spark generation in SMCs of tibial and mesenteric arteries.

![Line‐scan imaging of Ca^2+^‐release events (Ca^2+^ sparks) in wild‐type and smooth muscle (SM)--*Ryr2* ^*−/−*^ vascular SM cells (SMCs). **A**, Confocal line‐scan image of a Fluo‐3‐AM--loaded tibial artery wild‐type (control) cell showing the time course of Ca^2+^ sparks. The line‐scan image duration was 5 s, and each line was 4 ms. **B**, Ca^2+^ spark frequency in tibial artery SMCs from control (n=52) and SM‐*Ryr2* ^*−/−*^ (n=42) mice. \**P*\<0.05.](JAH3-8-e010090-g006){#jah33935-fig-0006}

RyR2‐Dependent Ca^2+^ Sparks Induce STOCs {#jah33935-sec-0027}
-----------------------------------------

In isolated myocytes under voltage‐clamp conditions, Ca^2+^ sparks activate a small number of proximate BK~Ca~ channels to cause a transient outward current, traditionally referred to as STOCs. STOCs were recorded in tibial artery SMCs from control and SM‐*Ryr2* ^*−/−*^ mice using the patch‐clamp technique (Figure [7](#jah33935-fig-0007){ref-type="fig"}). A peak amplitude \>28 pA above baseline, the criterion for a STOC at a holding potential of ‐20 mV, is 3 times the BK~Ca~ single‐channel current based on a conductance of 150 pS.[46](#jah33935-bib-0046){ref-type="ref"} Figure [7](#jah33935-fig-0007){ref-type="fig"}A shows recordings from a control VSMC at −40, −20, and 0 mV, demonstrating the presence of STOCs at −20 mV and more positive membrane potentials. In contrast, STOCs were absent in VSMCs from SM‐*Ryr2* ^*−/−*^ mice (Figure [7](#jah33935-fig-0007){ref-type="fig"}B). At −20 mV, 48% of control cells (n=31) exhibited STOCs, whereas no SM‐*Ryr2* ^*−/−*^ VSMCs (n=25) exhibited STOCs (Figure [7](#jah33935-fig-0007){ref-type="fig"}C). STOCs in control cells exhibited a frequency of 0.44±0.14 Hz (Figure [7](#jah33935-fig-0007){ref-type="fig"}D) and a mean amplitude of 26.5±6.0 pA at −20 mV (Figure [7](#jah33935-fig-0007){ref-type="fig"}E). Caffeine (10 mmol/L) induced a strong outward BK~Ca~ current in control VSMCs (Figure [S3](#jah33935-sup-0001){ref-type="supplementary-material"}A) that is attributable to an increase in global \[Ca^2+^\]~i~ in the micromolar range,[47](#jah33935-bib-0047){ref-type="ref"} followed by suppression of STOCs because of severe SR Ca^2+^ depletion. In contrast, caffeine failed to induce BK~Ca~ currents in SM‐*Ryr2* ^*−/−*^ VSMCs (Figure [S3](#jah33935-sup-0001){ref-type="supplementary-material"}B). These findings support the idea that RyR2s generate Ca^2+^ sparks in VSMCs, which, in turn, activate BK~Ca~ channels to produce STOCs. Notably, the Ca^2+^ ionophore A23187 (5 or 10 μmol/L) induced large outward BK~Ca~ currents in both control and SM‐*Ryr2* ^*−/−*^ VSMCs, indicating that BK~Ca~ channels are present and their Ca^2+^ sensitivity is preserved after ablation of *Ryr2* (Figure [8](#jah33935-fig-0008){ref-type="fig"}A and [8](#jah33935-fig-0008){ref-type="fig"}B).

![Spontaneous transient outward currents (STOCs) caused by Ca^2+^‐release events. **A** and **B**, Original recordings of STOCs in tibial artery smooth muscle (SM) cells isolated from wild‐type (control) (**A**) and SM‐*Ryr2* ^*−/−*^ (**B**) mice. The holding potential was stepwise increased in 20‐mV increments from −40 to 0 mV. **C** through **E**, Comparison of STOC characteristics at −20 mV. Percentage of cells with STOCs (**C**), STOC frequencies (**D**), and mean STOC amplitudes (**E**). n=31 cells of 11 control mice; n=25 cells of 9 SM‐*Ryr2* ^*−/−*^ mice. \**P*\<0.05.](JAH3-8-e010090-g007){#jah33935-fig-0007}

![Functional large‐conductance Ca^2+^‐sensitive K^+^ channels in wild‐type and smooth muscle (SM)--*Ryr2* ^*−/−*^ vascular SM cells (SMCs). **A**, Original current traces in wild‐type (control) and SM‐*Ryr2* ^*−/−*^ tibial artery SMCs before (control) and after application of 5 or 10 μmol/L A23187. **B**, Summary of the results (n=7 cells of 4 control mice; n=7 cells of 3 SM‐*Ryr2* ^*−/−*^ mice). I/I0, A23187‐induced current/basal current. n.s. indicates not significant.](JAH3-8-e010090-g008){#jah33935-fig-0008}

RyR2s in the Myogenic Response of Peripheral Arteries {#jah33935-sec-0028}
-----------------------------------------------------

We next tested the function of the RyR2 Ca^2+^ spark--BK~Ca~ channel pathway in opposing vasoconstriction to elevated transmural pressure (myogenic tone). Isolated mesenteric arteries were pressurized to 80 mm Hg and allowed to develop myogenic tone with a functional Ca^2+^ spark--BK~Ca~ channel pathway[34](#jah33935-bib-0034){ref-type="ref"} (Figure [9](#jah33935-fig-0009){ref-type="fig"}). The viability of vessels was confirmed by measuring the contractile response to a depolarizing concentration of KCl (60 mmol/L). The degree of myogenic tone in pressurized arteries was expressed relative to maximum diameter, determined by exposure to Ca^2+^‐free external PSS.[34](#jah33935-bib-0034){ref-type="ref"} Inhibition of the Ca^2+^ spark--BK~Ca~ channel pathway with the RyR inhibitor ryanodine (10 μmol/L)[48](#jah33935-bib-0048){ref-type="ref"} increased myogenic constriction in wild‐type (control) arteries (Figure [9](#jah33935-fig-0009){ref-type="fig"}A), consistent with previous reports.[6](#jah33935-bib-0006){ref-type="ref"}, [49](#jah33935-bib-0049){ref-type="ref"} In contrast, ryanodine had almost no effect on the diameters of arteries from SM‐*Ryr2* ^*−/−*^ mice (Figure [9](#jah33935-fig-0009){ref-type="fig"}B and [9](#jah33935-fig-0009){ref-type="fig"}C). These results indicate that the Ca^2+^ spark--BK~Ca~ channel pathway in VSMCs limits myogenic tone through RyR2s, without the involvement of other RyR isoforms.

![Arterial constriction induced by inhibition of Ca^2+^‐release events with ryanodine in wild‐type and smooth muscle (SM)--*Ryr2* ^*−/−*^ peripheral arteries. **A**, Application of ryanodine (10 μmol/L) provoked a strong constriction of isolated wild‐type (control) mesenteric arteries. **B**, Ryanodine‐induced constriction was reduced in SM‐*Ryr2* ^*−/−*^ arteries. **C**, Summary of the results (n=6 cells of 4 control mice; n=6 cells of 5 SM‐*Ryr2* ^*−/−*^ mice). The vertical gray and white bars in **A** and **B** represent the time points for the analyzed myogenic tone values. \**P*\<0.05.](JAH3-8-e010090-g009){#jah33935-fig-0009}

RyR2s in the Pulmonary Circulation {#jah33935-sec-0029}
----------------------------------

In the lung, alveolar hypoxia leads to constriction of upstream pulmonary arterioles through retrograde signal transduction via gap junctions.[50](#jah33935-bib-0050){ref-type="ref"} Using an ex vivo lung perfusion model, we investigated the role of VSMC RyR2s in the pulmonary artery pressure response to hypoxia. Basal mean pulmonary arterial pressure was not significantly different between control (10.3±0.2 cm H~2~O) and SM‐*Ryr2* ^*−/−*^ (11.0±0.3 cm H~2~O) lungs. There was also no difference in pulmonary arterial pressure between control and SM‐*Ryr2* ^*−/−*^ lungs during the short‐term phase of hypoxia (phase 1) (Figure [10](#jah33935-fig-0010){ref-type="fig"}A and [10](#jah33935-fig-0010){ref-type="fig"}B). However, under sustained hypoxia (phase 2), the increase in mean pulmonary arterial pressure was more pronounced in SM‐*Ryr2* ^*−/−*^ lungs than in control lungs (Figure [10](#jah33935-fig-0010){ref-type="fig"}A and [10](#jah33935-fig-0010){ref-type="fig"}B). This difference was observed over a wide range of flow rates (0.5--2.0 mL/min) (Figure [10](#jah33935-fig-0010){ref-type="fig"}C). Notably, flow‐induced increases in mean pulmonary arterial pressure did not differ between the 2 groups under normoxic conditions or in the short‐term phase of hypoxic pulmonary vasoconstriction (Figure [10](#jah33935-fig-0010){ref-type="fig"}C). These results argue for an important role of VSMC RyR2s in the sustained phase of hypoxic pulmonary vasoconstriction, but not in the short‐term phase. It is unlikely that SR Ca^2+^ release through VSMC RyR1 or RyR3 plays an important role in these effects because caffeine (10 mmol/L) induced a transient pulmonary vasoconstriction in control lungs, but not in SM‐*Ryr2* ^*−/−*^ lungs (Figure [10](#jah33935-fig-0010){ref-type="fig"}D and [10](#jah33935-fig-0010){ref-type="fig"}E).

![Function of ryanodine receptor type 2 (RyR2) in hypoxic pulmonary vasoconstriction. **A**, Changes in mean pulmonary arterial pressure (ΔPpa mean) observed in isolated perfused and ventilated lungs from wild‐type (control; closed squares, n=7 mice) and smooth muscle (SM)--*Ryr2* ^*−/−*^ (open squares, n=7 mice) mice after induction of hypoxic (1% O~2~) ventilation. **B**, Pulmonary pressure response (area under the curve \[AUC\]) in control and SM‐*Ryr2* ^*−/−*^ lungs attributable to short‐term (**left**, phase 1) and long‐term (**right**, phase 2) phases of hypoxic pulmonary vasoconstriction. **C**, Flow‐induced Ppa increase in control (closed symbols) and SM‐*Ryr2* ^*−/−*^ (open symbols) lungs under normoxia (squares), acute hypoxia (triangles), and chronic hypoxia (circles). **D**, Pulmonary pressure response after application of caffeine (10 mmol/L) in control (closed symbols) and SM‐*Ryr2* ^*−/−*^ (open symbols) lungs. Similar effects were observed with 3 consecutive applications of caffeine. **E**, The peak increase in Ppa caused by the first application of caffeine is shown. HPV, hypoxic pulmonary vasoconstriction; Q, flow rate. \**P*\<0.05.](JAH3-8-e010090-g010){#jah33935-fig-0010}

RyR2s in the Ischemic Hind Limb Circulation {#jah33935-sec-0030}
-------------------------------------------

RyRs may play a role in postischemic recovery of blood flow in the systemic peripheral circulation.[51](#jah33935-bib-0051){ref-type="ref"}, [52](#jah33935-bib-0052){ref-type="ref"}, [53](#jah33935-bib-0053){ref-type="ref"} In this setting, the magnitude of collateral flow strongly depends on the shear‐stress--induced outward remodeling response of preexisting collateral arteries in the hind limb.[54](#jah33935-bib-0054){ref-type="ref"}, [55](#jah33935-bib-0055){ref-type="ref"} To investigate the role of RyR2 in hind limb blood flow recovery after ligation of the femoral artery, we monitored perfusion of the right hind limb using the laser Doppler imaging technique and compared it with that in the intact left hind limb. There was no difference in blood flow recovery in the right hind limb in control compared with SM‐*Ryr2* ^*−/−*^ mice within 21 days after ligation (Figure [11](#jah33935-fig-0011){ref-type="fig"}). These results argue against an important role of RyR2 in postischemic recovery of blood flow. Changes in systemic blood pressure may mask the role of the gene(s) of interest in these effects. However, we found that tamoxifen induced only a 3-- to 4--mm Hg increase in mean arterial blood pressure in SM‐*Ryr2* ^*−/−*^ mice (Figure [12](#jah33935-fig-0012){ref-type="fig"}).

![Blood flow recovery after femoral artery ligation. **A**, Artery structure of right and left hind limbs of a wild‐type (control) mouse after polyurethane treatment. **Left:** Position of the femoral artery ligation is marked by an arrow. **B**, Recovery of right hind limb perfusion after femoral artery ligation in control (n=4--10) and smooth muscle (SM)--*Ryr2* ^*−/−*^ (n=3--8) mice relative to the left hind limb perfusion. *P*≥0.05 for all comparisons. Arrows mark native collateral arteries in the ligated and unligated hind limbs, revealing outward remodeling of arteries after femoral artery ligation. Native collateral arteries refer to collaterals I and II. Collateral III is newly developed within 1 to 3 weeks after the ligation.](JAH3-8-e010090-g011){#jah33935-fig-0011}

![Mean arterial blood pressure (MAP) in smooth muscle (SM)--*Ryr2* ^*−/−*^ mice. Time course of MAP (**A**), systolic blood pressure (SBP; **B**), diastolic blood pressure (DBP; **C**), and heart rate (implantation of the telemetric sensor at day 0; **D**) in SM‐*Ryr2* ^*−/−*^ mice. **E**, Summary of the results. Mean±SEM values were calculated for time intervals before (days 6--14) and after (days 21--29) tamoxifen administration (n=6 mice). Tamoxifen did not change these parameters in wild‐type (WT; control) mice (ΔMAP, −0.8 mm Hg; ΔSBP, −1.2 mm Hg; ΔDBP, 0.0 mm Hg; Δheart rate, 7.7 beats per minute \[bpm\]; no significant differences). **F**,MAP,SBP, and DBP did not change in WT mice before and after administration of tamoxifen (n=6 mice each).](JAH3-8-e010090-g012){#jah33935-fig-0012}

Discussion {#jah33935-sec-0031}
==========

Resistance arteries exhibit adaptive changes in their diameter in response to pressure and flow that are mediated by distinct mechanisms.[1](#jah33935-bib-0001){ref-type="ref"} Increases in transluminal *pressure* trigger an adaptive reduction in diameter. This myogenic response, which serves to normalize perfusion, is triggered by stretch‐sensitive mechanisms that operate in VSMCs.[34](#jah33935-bib-0034){ref-type="ref"} In contrast, increases in blood *flow* act via an increase in shear stress to trigger an increase in arterial diameter. Short‐term increases in blood flow/shear stress result in arterial dilation through a mechanism that involves the endothelial‐dependent NO pathway, whereas long‐term exposure to elevated shear stress causes a structural increase in the arterial lumen. This adaptive response requires activation of matrix metalloproteases that allow remodeling of the SM layers. In the current study, we tested the contribution of VSMC RyR2s to elementary Ca^2+^ signals and adaptive vascular responses to pressure and flow.

RyR2s Mediate Elementary SR Ca^2+^ Events in Arterial SMCs {#jah33935-sec-0032}
----------------------------------------------------------

Our results identify RyR2 as the key SR Ca^2+^‐release channel involved in generating Ca^2+^ sparks in VSMCs. In cardiac and skeletal muscle, the intimate association between triggering Ca~v~1.x L‐type channels and target RyRs is a prerequisite for generating Ca^2+^ sparks from a single Ca^2+^‐release unit.[56](#jah33935-bib-0056){ref-type="ref"}, [57](#jah33935-bib-0057){ref-type="ref"}, [58](#jah33935-bib-0058){ref-type="ref"}, [59](#jah33935-bib-0059){ref-type="ref"}, [60](#jah33935-bib-0060){ref-type="ref"}, [61](#jah33935-bib-0061){ref-type="ref"} Although RyR2 plays a major role in Ca~v~1.x/RyR coupling in cardiac muscle,[62](#jah33935-bib-0062){ref-type="ref"} RyR1 is crucial in skeletal muscle.[63](#jah33935-bib-0063){ref-type="ref"}, [64](#jah33935-bib-0064){ref-type="ref"} Although the importance of the Ca~v~1.2 Ca^2+^ channel for proper function of arterial VSMCs is well established, we previously demonstrated that Ca^2+^ spark generation in these cells does not rely on the intimate association between Ca~v~1.2 L‐type channels and RyRs.[30](#jah33935-bib-0030){ref-type="ref"} Instead, Ca~v~1.2 channels contribute to global cytosolic \[Ca^2+^\], which, in turn, influences luminal SR Ca^2+^ and thus Ca^2+^ sparks.[30](#jah33935-bib-0030){ref-type="ref"} In the present study, we investigated the contribution of RyR2s to Ca^2+^ sparks in arterial VSMCs. We found that RyR2s are essential for the development of Ca^2+^ sparks/STOCs in VSMCs and subsequent feedback regulation of myogenic tone in response to transmural *pressure*. We further found that RyR2s contribute to the pulmonary artery pressure response to sustained hypoxia but have no effect on *flow*‐induced responses. Finally, we found that RyR2s do not contribute to postischemic recovery of *blood flow* conductance in the peripheral systemic circulation, as shown in a hind limb occlusion model.

VSMC RyR2s in Peripheral Arteries and Vascular Adaptation to Pressure {#jah33935-sec-0033}
---------------------------------------------------------------------

Our data show that RyR2 is the major RyR isoform responsible for Ca^2+^ sparks in the VSMC Ca^2+^‐release unit of systemic arteries. We reach this conclusion for several reasons. First, Ca^2+^ sparks and STOCs were nearly abolished in SMCs of tibial and mesenteric arteries obtained from SM‐*Ryr2* ^*−/−*^ mice, suggesting an essential role for this RyR isoform in this process. This result contrasts with the role of RyR1 in Ca^2+^ spark generation in cultured VSMCs from portal veins, proposed by Coussin and colleagues,[23](#jah33935-bib-0023){ref-type="ref"} who suggested that both RyR1 and RyR2 contribute to spontaneous Ca^2+^ sparks. However, RyR Ca^2+^ signaling pathways delineated in cultured cells may reflect changes in protein expression that occur during cell dedifferentiation and may not represent a native feature of VSMCs. The findings reported herein extend our previous studies on *Ryr3* ^*−/−*^ mice,[25](#jah33935-bib-0025){ref-type="ref"} in which we showed that the frequencies of Ca^2+^ sparks and STOCs are increased in cerebral VSMCs from *Ryr3* ^*−/−*^ mice compared with those from wild‐type mice. To explain these results, we proposed that RyR3 acts as part of the SR Ca^2+^‐release unit to regulate the generation of Ca^2+^ sparks by RyR1 and/or RyR2.[25](#jah33935-bib-0025){ref-type="ref"} In contrast to the effects of *RyR3* ablation on frequency, Ca^2+^ spark and STOC amplitudes were normal in *Ryr3* ^*−/−*^ VSMCs, and caffeine induced normal global Ca^2+^ release in *Ryr3* ^*−/−*^ VSMCs. Second, we found that the pan RyR activator caffeine failed to induce global SR Ca^2+^ release and subsequent contraction of RyR2‐deficient aortae and femoral, tibial, mesenteric, cerebral, and pulmonary arteries. These results indicate that RyR2 is the only RyR isoform in VSMCs important for overall RyR‐mediated SR Ca^2+^ release in these vessels. This conclusion is supported by our finding that repeated applications of caffeine failed to induce contractions in mesenteric arteries of SM‐*Ryr2* ^*−/−*^ mice. Notably, vascular contractions in response to the α1‐adrenegic receptor agonist phenylephrine were normal in SM‐*Ryr2* ^*−/−*^ mesenteric arteries, suggesting a lack of cross talk between RyR2s and IP~3~‐sensitive Ca^2+^ pools sensitive to inositol 1,4,5‐trisphosphate (IP~3~) in the SR of VSMCs, at least in these vessels. Third, an RyR2 deficiency caused a reduction in vascular relaxation through malfunction of the Ca^2+^ spark--BK~Ca~ channel pathway. In these experiments, application of the RyR inhibitor ryanodine constricted control mesenteric arteries but caused almost no constriction of SM‐*Ryr2* ^*−/−*^ mesenteric arteries. These findings cannot be explained by a lack of functional BK~Ca~ channels in SM‐*Ryr2* ^*−/−*^ VSMCs because our patch‐clamp recordings showed normal BK~Ca~ channel currents in these cells in response to 5 to 10 μmol/L A23187, which increases global \[Ca^2+^\]~i~ to maximally activate BK~Ca~ channels.[47](#jah33935-bib-0047){ref-type="ref"} Finally, systemic blood pressure was increased in SM‐*Ryr2* ^*−/−*^ mice after genetic ablation of *Ryr2* in VSMCs. Although this increase was small (3--4 mm Hg), it was statistically significant. Notably, such a small difference is not surprising on the basis of experiments using mice deficient in the BK~Ca~ β1 subunit, which exhibit reduced functional coupling of Ca^2+^ sparks to BK~Ca~ channel activation. In these experiments, targeted deletion of the *Kcnmb1* gene encoding the BK~Ca~ β1 subunit increased systemic blood pressure by ≈10 mm Hg.[11](#jah33935-bib-0011){ref-type="ref"}, [12](#jah33935-bib-0012){ref-type="ref"}, [65](#jah33935-bib-0065){ref-type="ref"}, [66](#jah33935-bib-0066){ref-type="ref"} Taken together, these results strongly suggest that elementary SR Ca^2+^ release in VSMCs is mainly driven by Ca^2+^ flux through RyR2s. Accordingly, we suggest that RyR2s play a pivotal role in the generation of Ca^2+^ sparks, which, in turn, activate BK~Ca~ channels in VSMCs to limit arterial myogenic constriction in response to transmural pressure. Our results indicate that other RyR isoforms (RyR1 and RyR3) contribute minimally to physiologically relevant Ca^2+^ sparks in VSMCs of systemic arteries.

VSMC RyR2s in Hypoxic Pulmonary Vasoconstriction and Vascular Adaption to Flow {#jah33935-sec-0034}
------------------------------------------------------------------------------

Using pharmacological tools, Du et al[22](#jah33935-bib-0022){ref-type="ref"} suggested that RyRs exert an inhibitory regulatory role in the sustained phase of hypoxic vasoconstriction in the pulmonary circulation. Zheng et al[67](#jah33935-bib-0067){ref-type="ref"} attributed part of this hypoxic pulmonary constriction to the action of RyR3, whereas Li et al[26](#jah33935-bib-0026){ref-type="ref"} suggested a possible role for RyR1. However, both groups used constitutive (ie, nonconditional) targeting of RyRs, which might be associated with compensatory developmental upregulation of other RyR isoforms. By generating an inducible, SM‐specific RyR2‐knockout mouse model, we were able to investigate RyR2 function in the regulation of pulmonary arterial pressure and hypoxic pulmonary vasoconstriction. In normoxia and in the short‐term phase of hypoxia, we found no differences in the pulmonary arterial *pressure* response between control and SM‐*Ryr2* ^*−/−*^ lungs. However, our experiments revealed an important role of VSMC RyR2s in the sustained phase of hypoxic pulmonary vasoconstriction, although the molecular mechanisms are mostly unclear. Oxidative stress and accumulation of cADP‐ribose and 15‐lipoxygenase metabolites of arachidonic acid (eg, 15‐hydroxyeicosatetraenoic acid) have been implicated in ryanodine‐sensitive SR Ca^2+^ release in hypoxic pulmonary constriction.[68](#jah33935-bib-0068){ref-type="ref"}, [69](#jah33935-bib-0069){ref-type="ref"}, [70](#jah33935-bib-0070){ref-type="ref"}, [71](#jah33935-bib-0071){ref-type="ref"} Our results show that it is unlikely that SR Ca^2+^ release through RyR1 or RyR3 plays an important role in hypoxic pulmonary vasoconstriction because caffeine (10 mmol/L) was unable to evoke contractile responses in SM‐*Ryr2* ^*−/−*^ lungs. Although the BK~Ca~ channel itself is sensitive to hypoxia,[72](#jah33935-bib-0072){ref-type="ref"} it is possible that this channel is involved in hypoxic pulmonary vasoconstriction, because inhibition of BK~Ca~ channels by charybdotoxin (50 ng/mL \[≈10 nmol/L\]) or iberiotoxin (100 nmol/L) does not decrease hypoxic pulmonary vasoconstriction, but instead enhances vasopressor responses to ventilatory hypoxia in rats[73](#jah33935-bib-0073){ref-type="ref"} and rabbits.[74](#jah33935-bib-0074){ref-type="ref"} In addition, mice lacking the BK~Ca~ β1 subunit show normal pulmonary constriction to acute hypoxia.[75](#jah33935-bib-0075){ref-type="ref"} Future studies should explore the mechanisms by which the RyR2 isoform plays a protective role in sustained hypoxic pulmonary vasoconstriction. Plasma membrane stretch‐activated channels,[76](#jah33935-bib-0076){ref-type="ref"} TRPC1/6 channels (transient receptor potential canonical channels),[77](#jah33935-bib-0077){ref-type="ref"}, [78](#jah33935-bib-0078){ref-type="ref"}, [79](#jah33935-bib-0079){ref-type="ref"} NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase),[80](#jah33935-bib-0080){ref-type="ref"} and cytochrome P450--derived epoxyeicosatrienoic acids[75](#jah33935-bib-0075){ref-type="ref"} are promising candidate molecules to investigate in this context.

VSMC RyR2s in Hind Limb Ischemia and Vascular Adaptive Responses to Blood Flow {#jah33935-sec-0035}
------------------------------------------------------------------------------

To test if RyR2s affect shear stress--induced responses, we examined the remodeling of native hind limb collateral arteries. It is well established that long‐term increases in shear stress trigger the opening and outward remodeling of these preexisting bypasses.[54](#jah33935-bib-0054){ref-type="ref"}, [55](#jah33935-bib-0055){ref-type="ref"} An increase in the size of collateral arteries minimizes tissue injury and ischemia caused by vaso‐occlusive diseases, such as atherosclerosis. Using the mouse hind limb femoral artery ligation model[38](#jah33935-bib-0038){ref-type="ref"}, [81](#jah33935-bib-0081){ref-type="ref"} as an experimental model for monitoring collateral artery recruitment, flow and remodeling characteristics, and tissue ischemia in vivo, we found that SM‐*Ryr2* ^*−/−*^ mice and control mice showed comparable blood flow characteristics. We also observed a strong increase in collateral blood flow and collateral diameter in both mouse strains in the short‐term phase as well as long‐term (up to 3 weeks after occlusion). This lack of differences in functional blood flow recovery between the SM‐*Ryr2* ^*−/−*^ and wild‐type scenario suggests that, in this time period, RyR2 is not involved in adaptive remodeling of the peripheral vasculature; it neither mediates an acute dilation on changes in flow nor contributes to shear stress--mediated changes in arterial structural properties. Thus, although RyR2s have clear effects on VSMC Ca^2+^ sparks, shear‐stress--induced remodeling in peripheral hind limb ischemia appears normal in their absence. This is in sharp contrast to mice that are presumed to have altered Ca~v~1.2 channel expression, which affects tonic Ca^2+^ influx into VSMCs.[81](#jah33935-bib-0081){ref-type="ref"} These mice exhibit an almost complete absence of shear‐stress--induced arterial remodeling and collateral blood flow. Taken together, our data point toward a specific contribution of RyR2s in mediating VSMC Ca^2+^ sparks that is relevant to the regulation of myogenic tone (systemic circulation) and arterial remodeling in response to changes in *pressure* (lung model), but not *flow*.

In conclusion, RyR2 is the predominant functional RyR isoform involved in mediating Ca^2+^ sparks in VSMCs of mice. We found that SM‐specific genetic ablation of *Ryr2* substantially reduces Ca^2+^ sparks, which, in turn, prevents BK~Ca~ channel activation, thereby increasing myogenic constriction. We further established that VSMC RyR2s are important in regulating adaptive reductions in arterial diameter in response to *pressure*, but not *flow*. We also found that RyR2 provides a negative regulatory role in hypoxic vasoconstriction in the pulmonary circulation but does not contribute to postischemic recovery of blood flow conductance in the hind limb circulation. Our study potentially offers new possibilities for therapeutic interventions in systemic and pulmonary hypertension.
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**Figure S1.** Detection of RyR2 in hearts and different arteries of wild‐type and SM‐*Ryr2* ^*−/−*^ mice.

**Figure S2.** Ca^2+^ sparks in wild‐type and SM‐*Ryr2* ^*−/−*^ mesenteric artery SMCs.

**Figure S3.** BK~Ca~ channel currents in response to caffeine in wild‐type and SM‐*Ryr2* ^*−/−*^ VSMCs.
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